Table 3 shows the baseline pain score and duration of symptoms
Study ID | Pain (VAS)or (NRS) | Symptom duration (months) | Condition being studied | Intervention characteristics | ||
|---|---|---|---|---|---|---|
| Â | Mulligan | Placebo | Mulligan | Placebo | Â | Â |
Collins 2004 | NA | NA | NA | NA | subacute ankle sprains | Mulligan’s MWM |
Gogate 2020 | 5.9 ± 0.6 | 5.9 ± 0.6 | NA | NA | grade I and II inversion ankle sprain | mobilization with movement, manual therapy |
Nguyen 2021 | 2.4 ± 1.49 | 1.9 ± 1.66 | 2 ± 1.69 | 1.8 ± 1.61 | lateral ankle sprains (Grade I–II) | (MWM) or a sham |
Norouzi 2021 | 5.43 ± 1.26 | 6.00 ± 1.7 | NA | NA | grade two lateral ankle sprain | Maitland's mobilization & Mulligan's mobilization |
Phong Nguyen 2020 | 1.7 ± 1.49 | 1.1 ± 1.18 | 6 months | NA | Ankle injuries including ankle sprain | ITFMWM on the restricted and painful ankle |
Simsek 2018 | 2.93 ± 1.2 | 2.93 ± 1.2 | NA | NA | Chronic Ankle Instability | Mulligan distal fibular taping technique |
Alves 2018 | NA | NA | NA | NA | Chronic ankle instability | Mulligan fibular repositioning taping vs placebo taping |
Cruz-Diaz 2014 | NA | NA | NA | NA | Chronic ankle instability | Mulligan mobilization with movement vs sham mobilization vs control |
Reid 2007 | NA | NA | 24 | 24 | Chronic ankle instability | Mulligan mobilization with movement vs sham |
Shadegani 2023 | NA | NA | 14.29 ± 7.31 | 14.29 ± 7.31 | Chronic ankle instability | Kinesio taping vs Mulligan taping |